-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$482.5045.03% Upside
Bio-Rad Laboratories, Inc. Frequently Asked Questions
-
What analysts cover Bio-Rad Laboratories, Inc.?
Bio-Rad Laboratories, Inc. has been rated by research analysts at Citigroup, RBC Capital in the past 90 days.